|
|
| MRD / Regn No. |
: MH/23-24/00021 |
Date |
: 15/07/2026 |
| Patient Name |
: Saratha |
Age & Gender |
: 75 Yrs. / Female |
| Contact No. |
: 9901201342 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NO ALLERGIES |
Referred By |
: |
| |
|
| Salient Investigations |
: |
FASTING PLASMA GLUCOSE (FPG): 117 mg/dL | TOTAL CHOLESTEROL: 163 1 | TGL TRIGLYCERIDE: 188 mg/dL | HDL HIGH DENSITY LIPOPROTEIN: 45 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 85 mg/dL | TOTAL T3: 157 1 | TOTAL T4: 11.9 1 | TSH THYROID STIMULATING HORMONE: 3.63 mIU/L | UREA: 25 mg/dL | CREATININE: 0.6 1 | EGFR EGLOMERULAR FILTRATION RATE: 104.24 mL/min/1.73m2 | CALCIUM: 10.15 1 | URIC ACID: 6.2 | SODIUM: 140.8 meq/L | CHLORIDE: 103.58 meq/L | TOTAL BILIRUBIN: 0.55 mg/dL | DIRECT BILIRUBIN: 0.22 mg/DL | INDIRECT BILURUBIN: 0.33 | AST ASPARTATE AMINOTRANSFERASE: 27.7 U/L | ALT ALANINE AMINOTRANSFERASE: 32.2 IU/L | ALBUMIN: 4.54 g/dL | GLOBULIN: 3.04 | HB HEMOGLOBIN: 15 g/dL | RED BLOOD CELLS: 5.53 | WBC WHITE BLOOD CELLS: 10.49 K/uL | NEUTROPHILS: 45.7 | LYMPHOCYTES: 48.3 | MONOCYTES: 3 | EOSINOPHILS: 2.2 | HBA1C GLYCOSYLATED HEMOGLOBIN: 7 mg/dL |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
THYROXINE 100 MCG
THYRONORM 100 MCG |
ORAL |
1-0-0 |
EMPTY STOMACH
|
90 |
|
|
2 |
VILDAGLIPTIN METFOMIN 50/500 MG
JALRA M 50/500 |
ORAL |
1-0-1 |
AFTER FOOD
|
90 |
|
|
3 |
DAPAGLIFLOZIN 10 MG
OXRA |
ORAL |
1-0-0 |
AFTER FOOD
|
90 |
| T2DM | |
|
4 |
ROSUVASTATIN 5
ROZAVEL 5 |
ORAL |
0-0-1 |
AFTER FOOD
|
90 |
|
|
5 |
BISOPROLOL 5
CONCOR 5 |
ORAL |
1-0-0 |
AFTER FOOD
|
90 |
|
|
6 |
METHYLCOBALAMIN+ VITAMINS
MATILDA PLUS |
ORAL |
1-0-0 |
AFTER FOOD
|
90 |
|
|
7 |
GLICLAZIDE 80
GLYCINORM 80 |
ORAL |
0-0-1 |
BEFORE FOOD
|
90 |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 14/Aug/2026 |
| Tests Suggested For Next Visit |
: FASTING SUGAR,POST PRANDIAL SUGAR,LIPID PROFILE |
| |
|
| |
|
